Outset Medical announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.

Outset Medical plans to begin shipping the updated platform during the second quarter of 2026.

Outset Medical, Inc. OM recently announced that its next-generation Tablo hemodialysis system has received 510(k) clearance, ...

The next-generation Tablo platform is expected to begin shipping to customers in the second quarter of 2026. Healthcare providers currently using Tablo will be eligible to upgrade to the new ...

Investing.com -- Outset Medical Inc (NASDAQ:OM) stock jumped 9% in premarket trading Tuesday after the medical technology company announced FDA clearance for its next-generation Tablo dialysis ...

WHITMORE LAKE, Mich.--(BUSINESS WIRE)--Trace Medical, the national leader in advanced respiratory rentals and biomedical services, has announced a long-term distribution agreement with Outset Medical ...

Outset Medical is set to present at the prestigious 43rd annual J.P. Morgan Healthcare conference, which could enhance visibility and credibility within the healthcare sector. The company's innovative ...

Outset Medical shares have rallied more than 30% this month on news of the FDA approval. With the headwinds now behind it, the business has multiple positive catalysts going forward. Even though ...

Outset Medical, Inc. announced that it will release its financial results for the first quarter of 2025 on May 7, 2025, after market close. The company's Chair and CEO, Leslie Trigg, along with CFO ...

Detailed price information for Outset Medical Inc (OM-Q) from The Globe and Mail including charting and trades.